11/15
11:11 am
gnft
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus [Yahoo! Finance]
Low
Report
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus [Yahoo! Finance]
11/13
04:22 pm
gnft
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 [Yahoo! Finance]
High
Report
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 [Yahoo! Finance]
11/13
04:10 pm
gnft
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
High
Report
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
11/7
04:23 pm
gnft
GENFIT Reports Third Quarter 2024 Financial Information [Yahoo! Finance]
Medium
Report
GENFIT Reports Third Quarter 2024 Financial Information [Yahoo! Finance]
11/7
04:10 pm
gnft
GENFIT Reports Third Quarter 2024 Financial Information
Medium
Report
GENFIT Reports Third Quarter 2024 Financial Information
10/17
03:31 am
gnft
High Growth Tech Stocks in France for October 2024 [Yahoo! Finance]
Low
Report
High Growth Tech Stocks in France for October 2024 [Yahoo! Finance]
10/11
08:41 am
gnft
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Medium
Report
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
10/2
05:33 pm
gnft
Ipsen's IQIRVO Approval Has Intensified the Primary Biliary Cholangitis Market Space | DelveInsight [Yahoo! Finance]
Low
Report
Ipsen's IQIRVO Approval Has Intensified the Primary Biliary Cholangitis Market Space | DelveInsight [Yahoo! Finance]